Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation

Medical News Today, Article Date: 09 Jun 2011

Edison Pharmaceuticals, Inc. announced the United States Food and Drug Administration has granted orphan drug designation to EPI-743 for treatment of inherited mitochondrial respiratory chain diseases. read more